SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability

Haploinsufficiency Exonic splicing enhancer Loss function
DOI: 10.1016/j.ajhg.2023.03.016 Publication Date: 2023-04-17T14:28:37Z
ABSTRACT
SRSF1 (also known as ASF/SF2) is a non-small nuclear ribonucleoprotein (non-snRNP) that belongs to the arginine/serine (R/S) domain family. It recognizes and binds mRNA, regulating both constitutive alternative splicing. The complete loss of this proto-oncogene in mice embryonically lethal. Through international data sharing, we identified 17 individuals (10 females 7 males) with neurodevelopmental disorder (NDD) heterozygous germline variants, mostly de novo, including three frameshift nonsense seven missense two microdeletions within region 17q22 encompassing SRSF1. Only one family, novo origin could not be established. All featured recurrent phenotype developmental delay intellectual disability (DD/ID), hypotonia, neurobehavioral problems, variable skeletal (66.7%) cardiac (46%) anomalies. To investigate functional consequences performed silico structural modeling, developed an vivo splicing assay Drosophila, carried out episignature analysis blood-derived DNA from affected individuals. We found all loss-of-function 5 variants were pathogenic, leading activity correlating detectable specific methylation episignature. In addition, our orthogonal silico, vivo, epigenetics analyses enabled separation clearly pathogenic those uncertain significance. Overall, these results indicated haploinsufficiency responsible for syndromic NDD ID due partial SRSF1-mediated activity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (67)
CITATIONS (19)